Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
Clinical trial NCT02075463 · TERMINATED
Trial details
- NCT number
- NCT02075463
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-11
- Primary completion
- 2016-03-16
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.